Time: 2:00 – 3:00 p.m. ET
NHLBI is undertaking efforts to optimize its clinical trials enterprise, and toward that end, is working with its investigator community to foster trial success and maximize the benefits of this research to society and public health.
One area of focus is to facilitate the conduct and management of clinical trials by establishing early on clear milestones and metrics of progress through the Institute’s Funding Opportunity Announcements (FOAs) – the notices by which NHLBI solicits applications for research from its investigator community.
With extensive input from its stakeholders and advisory council, NHLBI has developed new milestone-driven FOAs for our multi-site clinical trials in Phase II and above. They are available at:
Clinical Coordinating Center for Multi-Site Investigator-Initiated Clinical Trials (Collaborative UG3/UH3)
Data Coordinating Center for Multi-Site Investigator-Initiated Clinical Trials (Collaborative U24)
In this webinar, NHLBI will:
- Provide an overview of NHLBI’s efforts to optimize its clinical trial enterprise, explaining how FOAs are a critical tool in that regard,
- Describe in depth NHLBI’s new process and expectations for applications responding to NHLBI FOAs for multi-site clinical trials in Phase II and above,
- Discuss the specific performance milestones and metrics that NHLBI expects applicants to include in their applications for these trials, and
- Answer investigator questions about NHLBI’s new approach, with an eye toward helping them prepare the best applications possible.
For more information about this event, please contact:
Amola Surya, ICF, NHLBI (Contractor)